Long-term improvement of QT dispersion is unaffected by short-term changes in blood pressure during treatment of systemic hypertension with enalapril

Annals of Noninvasive Electrocardiology

Volumn 8, Issue 1, 2003, Pages 47-54

  Seara, Francisco Javier García ^a   Juanatey, José Ramón González ^a   Sande, José Luis Martínez ^a   Veloso, Pedro Rigueiro ^a   Reino, Antonio Pose ^a   Román, Alfonso Varela ^a   Cerrato, José Cabezas ^a   De La Peña, Miguel Gil ^a  

^a University Hospital of Santiago de Compostela   (Spain)

Author keywords

Enalapril; Hypertension; Left ventricular mass; QT dispersion

Indexed keywords

ENALAPRIL; PLACEBO; ANTIHYPERTENSIVE AGENT;

ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR PARAMETERS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; M MODE ECHOCARDIOGRAPHY; MALE; NORMAL VALUE; PRIORITY JOURNAL; QT DISPERSION; QT INTERVAL; SUSPENSION; TWO DIMENSIONAL ECHOCARDIOGRAPHY; ADULT; AGED; COMORBIDITY; DRUG EFFECT; ELECTROCARDIOGRAPHY; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CONDUCTION SYSTEM; HEART STROKE VOLUME; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; COMORBIDITY; ELECTROCARDIOGRAPHY; ENALAPRIL; FEMALE; HEART CONDUCTION SYSTEM; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 2142853543     PISSN: 1082720X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1542-474X.2003.08108.x     Document Type: Article

References (38)

1. Zabel M, Portnoy S, Franz M. Electrocardiographic indices of dispersion of ventricular repolarization: An isolated heart validation study. J Am Coll Cardiol 1995;25:746-752.
2. Statters DJ, Malik M, Ward DE, et al. QT dispersion: Problems of methodology and clinical significance. J Cardiovasc Electrophysiol 1994;5:672-685.
3. Priori SG, Napolitano C, Diehl L, et al. Dispersion of the QT interval: A marker of therapeutic efficacy in the idiopathic long QT syndrome. Circulation 1994;89:1681-1689.
4. Glancy JM, Garrant CJ, Woods KL, et al. QT dispersion and mortality after myocardial infarction. Lancet 1995;354:945-948.
5. Perkiomaki JS, Koistinen J, Yli-Mayri S, et al. Dispersion of QT interval in patients with and without susceptibility to ventricular tachyarrhythmias after previous myocardial infarction. J Am Coll Cardiol 1995;26:174-179.
6. Baar CS, Nass A, Freemann M, et al. QT dispersion and sudden unexpected death in chronic heart failure. Lancet 1994;343:327-329.
7. Davey PP, Bateman J, Mulligan IP, et al. QT interval dispersion in chronic heart failure and left ventricular hypertrophy: Relation to autonomic nervous system and Holter tape abnormalities. Br Heart J 1994;71:268-273.
8. Pye M, Quinn AC, Cobbe SM. QT interval dispersion: A non-invasive marker of susceptibility to arrhythmia in patients with sustained ventricular arrhythmias. Br Heart J 1994;71:511-514.
9. Buja G, Miorelli M, Turrini P, et al. Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death. Am J Cardiol 1993;72:973-976.
10. Topol EJ, Lerman B. Hypomagnesemic torsades de pointes. Am J Cardiol 1983;52:1367-1368.
11. Elharrar V, Watanabe AM, Molello J, et al. Adrenergically mediated ventricular fibrillation in probucol-treated dogs. Roles of alpha and beta adrenergic receptors. PACE 1979;2:435-443.
12. Herrmann HC, Kaplan LM, Bierer BE. QT prolongation and torsade de pointes ventricular tachycardia produced by the tetracyclic antidepressant agent maprotiline. Am J Cardiol 1983;51:904-906.
13. Kors J, Van Herpen G, Van Bemmel J. QT Dispersion as an attribute of T-loop morphology. Circulation 1999;99:1458-1463.
14. González-Juanatey JR, Pose A, Varela A, et al. Evolution of left ventricular hypertrophy and function during long-term treatment of systemic hypertension with enalapril. Am J Cardio 1997;79:373-376.
15. González Juanatey JR, García Acuña JM, Pose A, et al. Reduction of QT and QTc dispersion during long-term treatment of systemic hypertension with enalapril. Am J Cardiol 1998;81:170-174.
16. Devereaux RB, Reichek N. Echocardiographic determination of left ventricular mass in men: Anatomic validation of the method. Circulation 1977;55:613-618.
17. Bazett HC. An analysis of the time relations of electrocardiograms. Heart 1920;7:353-370.
18. Zabel M, Franz MR, Klingenheben T, et al. Rate-dependence of QT dispersion and the QT interval: Comparison of atrial pacing and exercise testing. J Am Coll Cardiol 2000;36 (5):1654-1658.
19. Vassilikos VP, Karagounis LA, Psichogios A, et al. Correction for heart rate is not necessary for QT dispersion in individuals without structural heart disease and patients with ventricular tachycardia. Ann Noninvas Electrocardiol 2002;7(1):47-52.
20. Haider A, Larson M, Benjamin E, et al. Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol 1998;32:1454-1459.
21. Bikkina M, Larson M, Levy D. Asymptomatic ventricular arrhythmias and mortality risk in subjects with left ventricular hypertrophy. J Am Coll Cardiol 1993;22:1111-1116.
22. Schillaci G, Verdecchia P, Borgioni C, et al. Association between persistent pressure overload and ventricular arrhythmias in essential hypertension. Hypertension 1996;28:284-289.
23. Manolis A, Beldekos D, Handanis S, et al. Comparison of spirapril, isradipine or combination in hypertensive patients with left ventricular hypertrophy. Am J Hypertension 1998;11:640-648.
24. Verdecchia P, Schillaci G, Borgioni C, et al. Prognostic significance of serial changes in left ventricular mass in essential hypertension. Circulation 1998;97:48-54.
25. Muiesan L, Salvetti M, Rizzoni D, et al. Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment. J Hypertension 1995;13:1091-1095.
26. Ichkhan K, Molnar J, Somberg J. Relation of left ventricular mass and QT dispersion in patients with systematic hypertension. Am J Cardiol 1997;79:508-511.
27. Karpanou E, Vyssoulis G, Psichogios A, et al. Regression of left ventricular hypertrophy results in improvement of QT dispersion in patients with hypertension. Am Heart J 1998;136:765-768.
28. Mayet J, Shahi M, McGrath K, et al. Left ventricular hypertrophy and QT dispersion in hypertension. Hypertension 1996;28:791-796.
29. Darbar D, Cherry C, Kerins D. QT dispersion is reduced after valve replacement in patients with aortic stenosis. Heart 1999;82:15-18.
30. Galinier M, Balanescu S, Fourcade J, et al. Prognostic value of arrhythmogenic markers in systemic hypertension. Eur Heart J 1997;18:1484-1491.
31. Bugra Z, Koylan N, Vural A, et al. Left ventricular geometric patterns and QT dispersion in untreated essential hypertension. Am J Hypertension 1998;11:1164-1170.
32. Mäntari M, Oikarinen L, Manninen V, et al. QT dispersion as a risk factor for sudden cardiac death and fatal myocardial infarction in a coronary risk population. Heart 1997;78:268-272.
33. Vos M, De Groot S, Verduyn S, et al. Enhanced susceptibility for acquired Torsade de Pointes arrhythmias in the dog with chronic, complete AV block is related to cardiac hypertrophy and electrical remodeling. Circulation 1998; 98:1125-1135.
34. Guillis A, Mathison H, Kulisz E, et al. Dispersion of ventricular repolarization in left ventricular hypertrophy. J Cardiovasc Electrophysiol 1997;9:988-997.
35. McIntyre H, Fry C. Abnormal action potential conduction in isolated human hypertrophied left ventricular myocardium. J Cardiovasc Electrophysiol 1998;8:887-894.
36. Rials S, Wu Y, Ford N, et al. Effect of left ventricular hypertrophy and its regression on ventricular electrophysiology and vulnerability to inducible arrhythmia in the feline heart. Circulation 1995;91:426-430.
37. Rials SJ, Friehling TD, Marinchak RA. Potassium channels in cardiac arrhythmias: Focus on antiarrhythmic drug action. Prog Clin Biol Res 1990;334:111-121.
38. Kleiman RB, Houser SR. Calcium currents in normal and hypertrophied isolated feline ventricular myocytes. Am J Physiol 1988;255:1434-1442.